SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy
Stopped The DSMC March 16, 2022 reviewed of Interim Analysis and recommendation due to no glaring outcomes found to date.
Conditions
- Coronary Artery Disease
- Atherosclerosis
- Stent Placement
Interventions
- DRUG: Dual Antiplatelet (DAPT) Therapy
- DEVICE: The Synergy® stent
Sponsor
HonorHealth Research Institute
Collaborators